These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1173 related articles for article (PubMed ID: 15641020)

  • 1. Molecular mechanisms of drug resistance.
    Longley DB; Johnston PG
    J Pathol; 2005 Jan; 205(2):275-92. PubMed ID: 15641020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming drug resistance in patients with metastatic breast cancer.
    Wong ST; Goodin S
    Pharmacotherapy; 2009 Aug; 29(8):954-65. PubMed ID: 19637949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoropyrimidine resistance in colon cancer.
    Gorlick R; Banerjee D
    Expert Rev Anticancer Ther; 2002 Aug; 2(4):409-16. PubMed ID: 12647984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription factors and drug resistance.
    Kohno K; Uchiumi T; Niina I; Wakasugi T; Igarashi T; Momii Y; Yoshida T; Matsuo K; Miyamoto N; Izumi H
    Eur J Cancer; 2005 Nov; 41(16):2577-86. PubMed ID: 16209921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of tumor cell chemoresistance mechanisms.
    Gatti L; Zunino F
    Methods Mol Med; 2005; 111():127-48. PubMed ID: 15911977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer.
    Coley HM
    Cancer Treat Rev; 2008 Jun; 34(4):378-90. PubMed ID: 18367336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab-mediated chemosensitization of AIDS and non-AIDS non-Hodgkin's lymphoma.
    Bonavida B; Vega MI
    Drug Resist Updat; 2005; 8(1-2):27-41. PubMed ID: 15939340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis and therapy.
    Schmitt CA; Lowe SW
    J Pathol; 1999 Jan; 187(1):127-37. PubMed ID: 10341713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemo-signal therapy, an emerging new approach to modify drug resistance in breast cancer.
    Pusztai L; Esteva FJ; Cristofanilli M; Hung MC; Hortobagyi GN
    Cancer Treat Rev; 1999 Oct; 25(5):271-7. PubMed ID: 10544071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genes causing inherited cancer as beacons to identify the mechanisms of chemoresistance.
    Lønning PE
    Trends Mol Med; 2004 Mar; 10(3):113-8. PubMed ID: 15102353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting drug response based on gene expression.
    Robert J; Vekris A; Pourquier P; Bonnet J
    Crit Rev Oncol Hematol; 2004 Sep; 51(3):205-27. PubMed ID: 15331079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular processing of platinum anticancer drugs.
    Wang D; Lippard SJ
    Nat Rev Drug Discov; 2005 Apr; 4(4):307-20. PubMed ID: 15789122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistance mechanisms in cancer cells: a proteomics perspective.
    Verrills NM; Kavallaris M
    Curr Opin Mol Ther; 2003 Jun; 5(3):258-65. PubMed ID: 12870435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in cancer therapeutics: chemotherapy.
    DeVita VT
    Prog Clin Biol Res; 1983; 132A():47-69. PubMed ID: 6634746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistance in ovarian cancer: the emerging importance of gene transcription and spatio-temporal regulation of resistance.
    Richardson A; Kaye SB
    Drug Resist Updat; 2005 Oct; 8(5):311-21. PubMed ID: 16233989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Resistance of hematologic neoplasm cells to cytostatics. Part II].
    Kodydková K; Krejsek J
    Cas Lek Cesk; 2000 Sep; 139(19):591-5. PubMed ID: 11192750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of drug resistance in cancer chemotherapy.
    Luqmani YA
    Med Princ Pract; 2005; 14 Suppl 1():35-48. PubMed ID: 16103712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bypassing cancer drug resistance by activating multiple death pathways--a proposal from the study of circumventing cancer drug resistance by induction of necroptosis.
    Hu X; Xuan Y
    Cancer Lett; 2008 Feb; 259(2):127-37. PubMed ID: 18082322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG-island methylation and epigenetic control of resistance to chemotherapy.
    Teodoridis JM; Strathdee G; Plumb JA; Brown R
    Biochem Soc Trans; 2004 Dec; 32(Pt 6):916-7. PubMed ID: 15506923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.